→
Previous
Latest
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HB 1373 2021 A bill to be entitled An act relating to the Rare Disease Advisory Council;
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/HB 1373 2021 A bill to be entitled An act relating to the Rare Disease Advisory Council;
20.03(7), is created adjunct to the Department of Health for the purpose of providing recommendations on ways to improve health outcomes for individuals residing in this Page 1 of 5 CODING:
20.03(7), is created adjunct to the Department of Health for the purpose of providing recommendations on ways to improve health outcomes for individuals residing in the state Page 1 of 5 CODING:
hb1373-00 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HB 1373 2021 state who have a rare disease.
hb1373-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/HB 1373 2021 who have a rare disease.
(2) The advisory council is composed of the following members appointed by the Governor:
(2) The advisory council is composed of the following members:
(a) A representative of the Department of Health.
(a) As appointed by the Governor:
(b) A representative of the Agency for Health Care Administration.
1.
(c) A representative of the Office of Insurance Regulation.
A representative of the Department of Health.
(d) A representative of the Department of Education.
2.
(e) Two representatives from academic research institutions in this state which receive any grant funding for research regarding rare diseases.
A representative of the Agency for Health Care Administration.
(f) One geneticist practicing in this state.
3.
(g) One registered nurse or advanced practice registered nurse who is licensed and practicing in this state with experience treating rare diseases.
A representative of the Office of Insurance Regulation.
(h) Two physicians who are licensed and practicing in this state with experience treating rare diseases.
4.
(i) One hospital administrator from a hospital in this Page 2 of 5 CODING:
A representative of the Department of Education.
5.
One geneticist practicing in the state.
6.
One registered nurse or advanced practice registered nurse who is licensed and practicing in the state with experience in treating rare diseases.
7.
One hospital administrator from a hospital in the state which provides care to individuals diagnosed with rare diseases.
8.
A pharmacist who is licensed and practicing in the state who has experience with drugs that are used in the treatment of rare diseases.
9.
A representative of the biotechnology industry.
Page 2 of 5 CODING:
hb1373-00 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HB 1373 2021 state which provides care to individuals diagnosed with rare diseases.
hb1373-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/HB 1373 2021 10.
(j) Two individuals who are 18 years of age or older who have a rare disease.
A representative of health insurance companies.
(k) Two individuals who are caregivers of an individual with a rare disease.
(b) As appointed by the President of the Senate:
(l) Two representatives of organizations operating in this state which provide care or other support for individuals with rare diseases.
1.
(m) A pharmacist who is licensed and practicing in this state who has experience with drugs that are used to treat rare diseases.
A representative from an academic research institution in the state which receives grant funding for research regarding rare diseases.
(n) A representative of the biotechnology industry.
2.
(o) A representative of health insurance companies.
A physician who is licensed under chapter 458 or chapter 459 and practicing in the state with experience in treating rare diseases.
Any vacancy on the advisory council shall be filled in the same manner as the original appointment.
3.
(3) The initial members of the advisory council shall be appointed by September 1, 2021.
An individual who is 18 years of age or older who has a rare disease.
Each member shall be appointed to a 4-year term of office.
4.
However, in order to achieve staggered terms, the initial members appointed pursuant to paragraphs (2)(a)-(i) shall be appointed to a 2-year term.
An individual who is a caregiver of an individual with a rare disease.
The Governor shall designate a chair and vice chair of the advisory council from among its membership.
5.
The advisory council shall meet for its initial meeting by October 1, 2021.
A representative of an organization operating in the state which provides care or other support to individuals with rare diseases.
Thereafter, the Page 3 of 5 CODING:
(c) As appointed by the Speaker of the House of Representatives:
1.
A representative from an academic research institution in the state which receives grant funding for research regarding rare diseases.
Show all 66 changed rows (26 more)
Previous
Latest
2.
A physician who is licensed under chapter 458 or chapter 459 and practicing in the state with experience in treating rare diseases.
3.
An individual who is 18 years of age or older who has a rare disease.
Page 3 of 5 CODING:
hb1373-00 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HB 1373 2021 advisory council may meet upon the call of the chair or upon the request of a majority of its members.
hb1373-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/HB 1373 2021 4.
An individual who is a caregiver of an individual with a rare disease.
5.
A representative of organizations in the state which provide care or other support to individuals with rare diseases.
81 Any vacancy on the advisory council must be filled in the same manner as the original appointment.
(3) The initial members of the advisory council must be appointed by September 1, 2021.
Each member must be appointed to a 4-year term of office.
However, in order to achieve staggered terms, each of the initial members appointed pursuant to paragraph (2)(a) must be appointed to a 2-year term.
The Governor shall designate a chair and vice chair of the advisory council from among its membership.
The advisory council shall meet for its initial meeting by October 1, 2021.
Thereafter, the advisory council may meet upon the call of the chair or upon the request of a majority of its members.
(a) Consult with experts on rare diseases and solicit public comment to assist in developing recommendations on improving the treatment of rare diseases in this state.
(a) Consult with experts on rare diseases and solicit public comment to assist in developing recommendations on improving the treatment of rare diseases in the state.
(b) Develop recommended strategies for academic research institutions in this state to facilitate continued research on rare diseases.
(b) Develop recommended strategies for academic research Page 4 of 5 CODING:
Words stricken are deletions;
words underlined are additions.
hb1373-01-c1 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S CS/HB 1373 2021 institutions in the state to facilitate continued research on rare diseases.
(e) By July 1 of each year, beginning in 2022, submit a report to the Governor and the State Surgeon General which Page 4 of 5 CODING:
(e) By July 1 of each year, beginning in 2022, submit a report to the Governor and the State Surgeon General which describes the activities of the advisory council in the past year and its findings and recommendations regarding rare disease research and care.
Words stricken are deletions;
words underlined are additions.
hb1373-00 F L O R I D A H O U S E O F R E P R E S E N T A T I V E S HB 1373 2021 describes the activities of the advisory council in the past year and its findings and recommendations regarding rare disease research and care.
hb1373-00
hb1373-01-c1
⬇ Download PDF